These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 17488405

  • 1. Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases.
    Ulrich C, Hackethal M, Ulrich M, Howorka A, Forschner T, Sterry W, Stockfleth E.
    Br J Dermatol; 2007 May; 156 Suppl 3():40-2. PubMed ID: 17488405
    [Abstract] [Full Text] [Related]

  • 2. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C, Johannsen A, Röwert-Huber J, Ulrich M, Sterry W, Stockfleth E.
    Eur J Dermatol; 2010 May; 20(4):482-8. PubMed ID: 20507841
    [Abstract] [Full Text] [Related]

  • 3. Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze).
    Nelson C, Rigel D, Smith S, Swanson N, Wolf J.
    J Drugs Dermatol; 2004 May; 3(4):401-7. PubMed ID: 15303784
    [Abstract] [Full Text] [Related]

  • 4. Management of actinic cheilitis using diclofenac 3% gel: a report of six cases.
    Ulrich C, Forschner T, Ulrich M, Stockfleth E, Sterry W, Termeer C.
    Br J Dermatol; 2007 May; 156 Suppl 3():43-6. PubMed ID: 17488406
    [Abstract] [Full Text] [Related]

  • 5. An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
    Rivers JK, McLean DI.
    Arch Dermatol; 1997 Oct; 133(10):1239-42. PubMed ID: 9382562
    [Abstract] [Full Text] [Related]

  • 6. Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
    Patel MJ, Stockfleth E.
    Br J Dermatol; 2007 May; 156 Suppl 3():53-6. PubMed ID: 17488408
    [Abstract] [Full Text] [Related]

  • 7. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
    Berlin JM, Rigel DS.
    J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Topical photodynamic therapy of actinic keratosis in renal transplant recipients.
    Piaserico S, Belloni Fortina A, Rigotti P, Rossi B, Baldan N, Alaibac M, Marchini F.
    Transplant Proc; 2007 Jul; 39(6):1847-50. PubMed ID: 17692630
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetically determined susceptibility to COX-2 inhibitors: a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses.
    Patel MJ, Ulrich C, Forschner T.
    Br J Dermatol; 2007 May; 156 Suppl 3():57-61. PubMed ID: 17488409
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR, Morhenn VB, Piacquadio DJ.
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.